{"id":7607,"date":"2019-04-29T06:04:39","date_gmt":"2019-04-29T06:04:39","guid":{"rendered":"https:\/\/www.nicox.com\/nicox-participation-a-des-conferences-dindustrie-pharmaceutique-et-financiere\/"},"modified":"2019-04-29T06:04:39","modified_gmt":"2019-04-29T06:04:39","slug":"nicox-participation-a-des-conferences-dindustrie-pharmaceutique-et-financiere","status":"publish","type":"post","link":"https:\/\/www.nicox.com\/fr\/nicox-participation-a-des-conferences-dindustrie-pharmaceutique-et-financiere\/","title":{"rendered":"Nicox : Participation \u00e0 des conf\u00e9rences d\u2019industrie pharmaceutique et financi\u00e8re"},"content":{"rendered":"<p><strong>Nicox SA<\/strong> (Euronext Paris: FR0013018124, COX, \u00e9ligible PEA-PME), une soci\u00e9t\u00e9 internationale sp\u00e9cialis\u00e9e en ophtalmologie, annonce aujourd\u2019hui que la soci\u00e9t\u00e9 fera des pr\u00e9sentations aux conf\u00e9rences d\u2019industrie pharmaceutique et financi\u00e8re suivantes au cours du deuxi\u00e8me trimestre 2019 :<\/p>\n<ul>\n<li>Michele Garufi, Pr\u00e9sident Directeur G\u00e9n\u00e9ral, fera une pr\u00e9sentation le <strong>2 mai 2019<\/strong> \u00e0 la conf\u00e9rence <strong>Ophthalmology Innovation Summit (OIS)<\/strong>, avant la r\u00e9union annuelle 2019 de l\u2019American Society of Cataract and Refractive Surgery (ASCRS). La conf\u00e9rence se tiendra au Hilton San Diego Bayfront, San Diego, Etats-Unis.<\/li>\n<li>Gavin Spencer, Chief Business Officer, fera une pr\u00e9sentation \u00e0 la <strong>conf\u00e9rence JMP Securities Life Sciences le 20 juin 2019<\/strong> \u00e0 l\u2019h\u00f4tel St Regis, New York, Etats-Unis.<\/li>\n<li>Emmet Purtill, Senior Director, Buiness Development, fera une pr\u00e9sentation \u00e0 la <strong>Convention Internationale BIO 2019<\/strong> qui se tiendra \u00e0 Philadelphie, Etats-Unis, du <strong>3 au 6 juin 2019<\/strong>.<\/li>\n<\/ul>\n<p>Les pr\u00e9sentations seront accessibles sur le site Internet de Nicox (www.nicox.com) \u00e0 la rubrique Pr\u00e9sentations et \u00c9v\u00e8nements.<\/p>\n<p>L\u2019\u00e9quipe dirigeante de Nicox participera \u00e9galement aux \u00e9v\u00e8nements suivants pour des r\u00e9unions individuelles avec des investisseurs\u00a0:<\/p>\n<ul>\n<li>16 mai\u00a0: European MidCap Event, Copenhague, Danemark<\/li>\n<li>18-19 juin\u00a0: European MidCap Event, Paris, France<\/li>\n<li>24-25 juin\u00a0: HealthTech Investor Day, Paris, France<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Nicox SA (Euronext Paris: FR0013018124, COX, \u00e9ligible PEA-PME), une soci\u00e9t\u00e9 internationale sp\u00e9cialis\u00e9e en ophtalmologie, annonce aujourd\u2019hui que la soci\u00e9t\u00e9 fera des pr\u00e9sentations aux conf\u00e9rences d\u2019industrie pharmaceutique et financi\u00e8re suivantes au cours du deuxi\u00e8me trimestre 2019 : Michele Garufi, Pr\u00e9sident Directeur G\u00e9n\u00e9ral, fera une pr\u00e9sentation le 2 mai 2019 \u00e0 la conf\u00e9rence Ophthalmology Innovation Summit (OIS), [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[32,16],"tags":[],"class_list":["post-7607","post","type-post","status-publish","format-standard","hentry","category-actualites","category-actualites-et-media"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nicox : Participation \u00e0 des conf\u00e9rences d\u2019industrie pharmaceutique et financi\u00e8re - Nicox<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.nicox.com\/fr\/nicox-participation-a-des-conferences-dindustrie-pharmaceutique-et-financiere\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nicox : Participation \u00e0 des conf\u00e9rences d\u2019industrie pharmaceutique et financi\u00e8re - Nicox\" \/>\n<meta property=\"og:description\" content=\"Nicox SA (Euronext Paris: FR0013018124, COX, \u00e9ligible PEA-PME), une soci\u00e9t\u00e9 internationale sp\u00e9cialis\u00e9e en ophtalmologie, annonce aujourd\u2019hui que la soci\u00e9t\u00e9 fera des pr\u00e9sentations aux conf\u00e9rences d\u2019industrie pharmaceutique et financi\u00e8re suivantes au cours du deuxi\u00e8me trimestre 2019 : Michele Garufi, Pr\u00e9sident Directeur G\u00e9n\u00e9ral, fera une pr\u00e9sentation le 2 mai 2019 \u00e0 la conf\u00e9rence Ophthalmology Innovation Summit (OIS), [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.nicox.com\/fr\/nicox-participation-a-des-conferences-dindustrie-pharmaceutique-et-financiere\/\" \/>\n<meta property=\"og:site_name\" content=\"Nicox\" \/>\n<meta property=\"article:published_time\" content=\"2019-04-29T06:04:39+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-participation-a-des-conferences-dindustrie-pharmaceutique-et-financiere\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-participation-a-des-conferences-dindustrie-pharmaceutique-et-financiere\\\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Nicox : Participation \u00e0 des conf\u00e9rences d\u2019industrie pharmaceutique et financi\u00e8re\",\"datePublished\":\"2019-04-29T06:04:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-participation-a-des-conferences-dindustrie-pharmaceutique-et-financiere\\\/\"},\"wordCount\":212,\"publisher\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#organization\"},\"articleSection\":[\"Actualit\u00e9s\",\"Actualit\u00e9s et M\u00e9dia\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-participation-a-des-conferences-dindustrie-pharmaceutique-et-financiere\\\/\",\"url\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-participation-a-des-conferences-dindustrie-pharmaceutique-et-financiere\\\/\",\"name\":\"Nicox : Participation \u00e0 des conf\u00e9rences d\u2019industrie pharmaceutique et financi\u00e8re - Nicox\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#website\"},\"datePublished\":\"2019-04-29T06:04:39+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-participation-a-des-conferences-dindustrie-pharmaceutique-et-financiere\\\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/\",\"name\":\"Nicox\",\"description\":\"Visible Science\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#organization\",\"name\":\"Nicox\",\"url\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Nicox\"},\"image\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nicox : Participation \u00e0 des conf\u00e9rences d\u2019industrie pharmaceutique et financi\u00e8re - Nicox","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.nicox.com\/fr\/nicox-participation-a-des-conferences-dindustrie-pharmaceutique-et-financiere\/","og_locale":"fr_FR","og_type":"article","og_title":"Nicox : Participation \u00e0 des conf\u00e9rences d\u2019industrie pharmaceutique et financi\u00e8re - Nicox","og_description":"Nicox SA (Euronext Paris: FR0013018124, COX, \u00e9ligible PEA-PME), une soci\u00e9t\u00e9 internationale sp\u00e9cialis\u00e9e en ophtalmologie, annonce aujourd\u2019hui que la soci\u00e9t\u00e9 fera des pr\u00e9sentations aux conf\u00e9rences d\u2019industrie pharmaceutique et financi\u00e8re suivantes au cours du deuxi\u00e8me trimestre 2019 : Michele Garufi, Pr\u00e9sident Directeur G\u00e9n\u00e9ral, fera une pr\u00e9sentation le 2 mai 2019 \u00e0 la conf\u00e9rence Ophthalmology Innovation Summit (OIS), [&hellip;]","og_url":"https:\/\/www.nicox.com\/fr\/nicox-participation-a-des-conferences-dindustrie-pharmaceutique-et-financiere\/","og_site_name":"Nicox","article_published_time":"2019-04-29T06:04:39+00:00","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.nicox.com\/fr\/nicox-participation-a-des-conferences-dindustrie-pharmaceutique-et-financiere\/#article","isPartOf":{"@id":"https:\/\/www.nicox.com\/fr\/nicox-participation-a-des-conferences-dindustrie-pharmaceutique-et-financiere\/"},"author":{"name":"","@id":""},"headline":"Nicox : Participation \u00e0 des conf\u00e9rences d\u2019industrie pharmaceutique et financi\u00e8re","datePublished":"2019-04-29T06:04:39+00:00","mainEntityOfPage":{"@id":"https:\/\/www.nicox.com\/fr\/nicox-participation-a-des-conferences-dindustrie-pharmaceutique-et-financiere\/"},"wordCount":212,"publisher":{"@id":"https:\/\/www.nicox.com\/fr\/#organization"},"articleSection":["Actualit\u00e9s","Actualit\u00e9s et M\u00e9dia"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.nicox.com\/fr\/nicox-participation-a-des-conferences-dindustrie-pharmaceutique-et-financiere\/","url":"https:\/\/www.nicox.com\/fr\/nicox-participation-a-des-conferences-dindustrie-pharmaceutique-et-financiere\/","name":"Nicox : Participation \u00e0 des conf\u00e9rences d\u2019industrie pharmaceutique et financi\u00e8re - Nicox","isPartOf":{"@id":"https:\/\/www.nicox.com\/fr\/#website"},"datePublished":"2019-04-29T06:04:39+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.nicox.com\/fr\/nicox-participation-a-des-conferences-dindustrie-pharmaceutique-et-financiere\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.nicox.com\/fr\/#website","url":"https:\/\/www.nicox.com\/fr\/","name":"Nicox","description":"Visible Science","publisher":{"@id":"https:\/\/www.nicox.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.nicox.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.nicox.com\/fr\/#organization","name":"Nicox","url":"https:\/\/www.nicox.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.nicox.com\/fr\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Nicox"},"image":{"@id":"https:\/\/www.nicox.com\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":""}]}},"_links":{"self":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/posts\/7607","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/comments?post=7607"}],"version-history":[{"count":0,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/posts\/7607\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/media?parent=7607"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/categories?post=7607"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/tags?post=7607"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}